J&J | Eiendeler




Assets Endring Dato
AbbVie USD 135.16B 8.26B 2024-12
Abbott USD 81.41B 7.06B 2024-12
Amgen USD 91.84B 956M 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Biogen USD 28.05B 263.9M 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
CONMED USD 2.31B 9.5M 2024-12
Cooper Companies USD 12.22B 93M 2025-01
Dexcom USD 6.48B 130.7M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Globus Medical USD 5.25B 165.71M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Indivior 1.46B 71M 2024-09
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
Intuitive Surgical USD 18.74B 999.8M 2024-12
J&J USD 180.1B 1.82B 2024-12
Medtronic USD 89.97B 69M 2025-01
Merck USD 117.11B 426M 2024-12
Merit Medical Systems USD 2.42B 40.52M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 129.76B 3.29B 2024-06
Stryker USD 42.97B 862M 2024-12
Tandem Diabetes Care USD 967.66M 9.93M 2024-12
Teva Pharmaceutical Industries USD 39.33B 2.43B 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12
Zoetis USD 14.24B 120M 2024-12



J&J Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.